Literature DB >> 27986840

Dedicated health systems strengthening of the Global Fund to Fight AIDS, Tuberculosis, and Malaria: an analysis of grants.

Victoria Y Fan1,2, Feng-Jen J Tsai3, Zubin C Shroff4, Branden Nakahara5, Nabil Vargha5, Scott Weathers2.   

Abstract

BACKGROUND: This study aims to understand the determinants of the Global Fund to Fight AIDS, Tuberculosis, and Malaria's dedicated channel for health systems strengthening (HSS) funding across countries and to analyze their health system priorities expressed in budgets and performance indicators.
METHODS: We obtained publicly available data for disease-specific and HSS grants from the Global Fund over 2004-2013 prior to the new funding model. Regression analysis was employed to assess the determinants of dedicated HSS funding across 111 countries. Documents for 27 dedicated HSS grants including budgets and performance indicators were collected, and activities were analyzed by health system functions.
RESULTS: HSS funding per capita is significantly associated with TB and HIV funding per capita, but not per capita income and health worker density. Of 27 dedicated HSS grants, 11 had line-item budgets publicly available, in which health workforce and medical products form the majority (89% or US$132 million of US$148 million) of funds. Yet these areas accounted for 41.7% (215) of total 516 performance indicators.
CONCLUSIONS: Health worker densities were not correlated with HSS funding, despite the emphasis on health workforce in budgets and performance indicators. Priorities in health systems in line-item budgets differ from the numbers of indicators used.
© The Author 2016. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Global Fund to Fight AIDS, Tuberculosis, and Malaria; Global Health; Global Health Initiative; Health systems; Health systems strengthening; World Health Organization

Mesh:

Year:  2016        PMID: 27986840     DOI: 10.1093/inthealth/ihw055

Source DB:  PubMed          Journal:  Int Health        ISSN: 1876-3405            Impact factor:   2.473


  7 in total

1.  The Investment Case for Malaria Elimination in Thailand: A Cost-Benefit Analysis.

Authors:  Prayuth Sudathip; Darin Kongkasuriyachai; Rachel Stelmach; Donal Bisanzio; Jeffrey Sine; Surasak Sawang; Suravadee Kitchakarn; David Sintasath; Richard Reithinger
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

2.  A road map for the global elimination of congenital syphilis.

Authors:  Mary L Kamb; Lori M Newman; Patricia L Riley; Jennifer Mark; Sarah J Hawkes; Tasneem Malik; Nathalie Broutet
Journal:  Obstet Gynecol Int       Date:  2010-07-14

3.  The Global Fund's paradigm of oversight, monitoring, and results in Mozambique.

Authors:  Ashley Warren; Roberto Cordon; Michaela Told; Don de Savigny; Ilona Kickbusch; Marcel Tanner
Journal:  Global Health       Date:  2017-12-12       Impact factor: 4.185

4.  A systematic examination of international funding flows for Ebola virus and Zika virus outbreaks 2014-2019: donors, recipients and funding purposes.

Authors:  Emily Jade Quirk; Adrian Gheorghe; Katharina Hauck
Journal:  BMJ Glob Health       Date:  2021-04

5.  ``Now it is mostly done through stashes, to do it in person one has to trust you'': Understanding the retail injection drug market in Dnipro, Ukraine.

Authors:  Alyona Mazhnaya; Tetiana Kiriazova; Olena Chernova; Karin Tobin; Jill Owczarzak
Journal:  Int J Drug Policy       Date:  2020-10-28

6.  Indoor Residual Spraying Delivery Models to Prevent Malaria: Comparison of Community- and District-Based Approaches in Ethiopia.

Authors:  Benjamin Johns; Yemane Yeebiyo Yihdego; Lena Kolyada; Dereje Dengela; Sheleme Chibsa; Gunawardena Dissanayake; Kristen George; Hiwot Solomon Taffese; Bradford Lucas
Journal:  Glob Health Sci Pract       Date:  2016-12-28

7.  Securitizing HIV/AIDS: a game changer in state-societal relations in China?

Authors:  Catherine Yuk-Ping Lo
Journal:  Global Health       Date:  2018-05-16       Impact factor: 4.185

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.